中药“球康”防治球虫病的研究(一)——球康与AC—1和杜球对试验性鸡感染混合艾美尔球虫的疗效比较

STUDY ON A NEW COCCIDIOSAT “QIUKANG”(I) COMPARATIVE EIFFICACY OF “QIUKANG”,AC-1 AND MADURAMYCIN AGAINST COCCIDIOSIS IN EXPERIMENTALLY INFECTED CHICKEN

对无球虫雏鸡人工接种艾美尔球虫混合卵囊(E.tenella,E.maxima,E.acervulina),用中药“球康”两个组方与AC—1、杜球进行疗效比较试验,以雏鸡存活率、抗球虫指数作疗效综合评判指标,结果显示:“球康”Ⅰ、“球康”Ⅱ组的雏鸡存活率和抗球虫指数分别为90％、100％和123.6、179.7。AC—1和杜球组雏鸡存活率和抗球虫指数分别为100％、95％和190.9.187,而接种感染不给药组的存活率为0,抗球虫指数50.5。由此表明,初次拟定的中药“球康”两个组方在强毒卵囊的攻击下,表现出有较好的防治效果。

The efficacy of 'Qiukang' , one of the traditional Chinese drugs formulas, against coccidiosis was compared with AC-1 (diclazuril) and Maduramycin in experimentally infected chickens. The prophylaxis against coccidiosis was evaluted using a mixed infection of Eimeria tenella 10 ×104, E. maxima 1.3×104 and E.acervlina 3.8×1 04 with Qiukang Ⅰ (0.5%), Qiukang S (0.5%), AC-1(lppm) and Maduramycin (5ppm) in continuous medicated feed. The results showed that the survival ratio of Qiukang Ⅰ , Qiukang Ⅱ, AC-1 and Maduramycin were 90%, 100%, 100% and 95%, and that the anticoccidial index were 123. 5, 179. 7, 190. 9 and 187, respectively. Qiukang I was more effective than Qiukang I in controlling chicken coccidiosis.